Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2023 Filed May 2, 2023 20:12 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 2,800 | $41.93 | $117,404.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2023 Filed Feb 7, 2024 02:46 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
OtherCommon Stock | 1.635 | $102.39 | $167.40 |
DisclosureSEC source: 0001127602-24-003608 · form5.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,712.635 Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:16 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
GrantCommon Stock | 40 | $98.67 | $3,946.80 |
DisclosureSEC source: 0001127602-23-012185 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,088 Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:14 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantCommon Stock | 240 | $98.67 | $23,680.80 |
DisclosureSEC source: 0001127602-23-012179 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,355 Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:11 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
GrantCommon Stock | 219 | $98.67 | $21,608.73 |
DisclosureSEC source: 0001127602-23-012168 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,997 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 20:17 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
SaleCommon Stock | 5,000 | $92.81 | $464,028.50 |
DisclosureSEC source: 0001127602-23-010291 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,299 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.76 to $92.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 30,000 | $0.00 Strike: $50.61 | $0.00 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · derivative · entry 7 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 Underlying: Common Stock · 30,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 100 | $92.63 | $9,263.00 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 6 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115 Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 3,825 | $91.95 | $351,690.39 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 5 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,215 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.625 to $92.45. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 17,926 | $91.10 | $1,633,074.73 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 4 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,040 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.615 to $91.61. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 6,849 | $90.30 | $618,494.84 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,966 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.61 to $90.595. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 1,300 | $88.78 | $115,416.47 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,815 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.15 to $88.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 30,000 | $50.61 | $1,518,300.00 |
DisclosureSEC source: 0001127602-23-010058 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 16:22 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 75 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009539 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225 Underlying: Common Stock · 75 shares Expires 2032-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 16:22 UTC |
Lalomia BrentVice President QA and RA
|
Tax withholdingCommon Stock | 26 | $95.32 | $2,478.32 |
DisclosureSEC source: 0001127602-23-009539 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729.057 Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 16:22 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009539 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 755.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · derivative · entry 10 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · derivative · entry 9 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,400 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
SaleCommon Stock | 5,000 | $96.08 | $480,381.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 6 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
Exercise / conversionCommon Stock | 5,000 | $78.76 | $393,800.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 5 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
SaleCommon Stock | 5,400 | $96.25 | $519,723.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 4 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
Exercise / conversionCommon Stock | 5,400 | $59.96 | $323,784.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 3 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:23 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
GrantOptions To Purchase Common Stock · Derivative | 15,159 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008932 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,159 Underlying: Common Stock · 15,159 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:21 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
GrantOptions To Purchase Common Stock · Derivative | 20,843 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008927 · form4.xml · derivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,843 Underlying: Common Stock · 20,843 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:19 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
GrantOptions To Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008924 · form4.xml · derivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:17 UTC |
Lalomia BrentVice President QA and RA
|
GrantOptions To Purchase Common Stock · Derivative | 12,317 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008921 · form4.xml · derivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,317 Underlying: Common Stock · 12,317 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:15 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
GrantOptions To Purchase Common Stock · Derivative | 67,141 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008915 · form4.xml · derivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,141 Underlying: Common Stock · 67,141 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantOptions To Purchase Common Stock · Derivative | 32,212 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008912 · form4.xml · derivative · entry 4 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,212 Underlying: Common Stock · 32,212 shares Expires 2033-03-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008912 · form4.xml · derivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,600 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC |
Garner Todd WExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 486 | $96.16 | $46,733.76 |
DisclosureSEC source: 0001127602-23-008912 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008912 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:11 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
GrantOptions To Purchase Common Stock · Derivative | 18,948 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008908 · form4.xml · derivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,948 Underlying: Common Stock · 18,948 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:08 UTC |
Beyer PatPresident Int'l & Global Ortho
|
GrantOptions To Purchase Common Stock · Derivative | 32,212 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008906 · form4.xml · derivative · entry 1 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,212 Underlying: Common Stock · 32,212 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:06 UTC |
Berge Terence MVP-Corporate Controller
|
GrantOptions To Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008902 · form4.xml · derivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
GrantRsus (restricted Stock Units) · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · derivative · entry 8 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2033-03-01 F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · derivative · entry 7 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
Tax withholdingCommon Stock | 736 | $96.16 | $70,773.76 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 2 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:45 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 14:55 UTC Amendment |
Peterson JaclynVP of Mfg. & Adv. Engineering
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008541 · form4a.xml · derivative · entry 3 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 250 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 14:55 UTC Amendment |
Peterson JaclynVP of Mfg. & Adv. Engineering
|
Tax withholdingCommon Stock | 90 | $96.16 | $8,654.40 |
DisclosureSEC source: 0001127602-23-008541 · form4a.xml · nonDerivative · entry 2 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 739 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 14:55 UTC Amendment |
Peterson JaclynVP of Mfg. & Adv. Engineering
|
Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008541 · form4a.xml · nonDerivative · entry 1 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2022 Filed Feb 6, 2023 21:16 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Other401 (K) Plan | 112.168 | $88.64 | $9,942.57 |
DisclosureSEC source: 0001127602-23-003558 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 1,313.194 F1 · date: As of December 31, 2022. Read SEC document |
| December 31, 2022 Filed Feb 6, 2023 21:07 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
Other401 (K) Plan | 35.456 | $88.64 | $3,142.82 |
DisclosureSEC source: 0001127602-23-003554 · form5.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 4,971.166 F1 · date: As of December 31, 2022. F2 · date: As of December 31, 2022. Read SEC document |
| December 30, 2022 Filed Jan 10, 2023 21:47 UTC |
Jonas Daniel SSpecial Counsel & Corp Secy
|
GrantCommon Stock | 24 | $84.21 | $2,021.04 |
DisclosureSEC source: 0001127602-23-001227 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,284 Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 23:44 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
Disposition to issuerCommon Stock | 5,118 | $96.79 | $495,371.22 |
DisclosureSEC source: 0001127602-22-027489 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 83,500 F1 · kind: The Reporting person disclaims beneficial ownership of the shares held by or disposed of by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owners of the shares held by or disposed of by the trust for purposes of Section 16 or for any other purpose. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 23:44 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
Disposition to issuerCommon Stock | 382 | $96.60 | $36,901.20 |
DisclosureSEC source: 0001127602-22-027489 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 88,618 F1 · kind: The Reporting person disclaims beneficial ownership of the shares held by or disposed of by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owners of the shares held by or disposed of by the trust for purposes of Section 16 or for any other purpose. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 22:08 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,500 | $0.00 Strike: $50.61 | $0.00 |
DisclosureSEC source: 0001127602-22-027324 · form4.xml · derivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,100 Underlying: Common Stock · 4,500 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 22:08 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 4,500 | $89.31 | $401,895.00 |
DisclosureSEC source: 0001127602-22-027324 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 F1 · kind: The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 22:08 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 4,500 | $50.61 | $227,745.00 |
DisclosureSEC source: 0001127602-22-027324 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2022 Filed Feb 10, 2023 23:44 UTC |
Lalomia BrentVice President QA and RA
|
OtherCommon Stock | 1.32 | $81.63 | $107.75 |
DisclosureSEC source: 0001127602-23-004576 · form5.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680.057 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.